Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting New Receptors in Dystonia: Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem, a Selective Agonist of Benzodiazepine Subtype Receptor alfa1, in Different Forms of Primary Focal Dystonia

NCT04692285 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.

NCT NCT04692285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04692285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting New Receptors in Dystonia: Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem, a Selective Agonist of Benzodiazepine Subtype Receptor alfa1, in Different Forms of Primary Focal Dystonia
Lead sponsor
University Medical Centre Ljubljana
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2017
Completion date
April 30, 2021
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

focal dystonia